Class of severely disabled Medicaid recipients challenged Florida’s decision to deny coverage of a prescription drug, Neurontin, for medically accepted indications that were cited in congressionally-recognized drug compendia, including neuropathic pain and certain psychiatric disorders, in violation of the Medicaid Act.
In "Detrimental Effects of Allowing States to Waive the Essential Health Benefits," Senior Attorney Michelle Lilienfeld and Staff Attorney Héctor Hernández-Delgado explain how…